Fertility preservation in patients with medical indications: a committee opinion

Practice Committee of the American Society for Reproductive Medicine

doi:10.1016/j.fertnstert.2025.12.001

Fertility preservation in patients with medical indications: a committee opinion

Practice Committee of the American Society for Reproductive Medicine

Department of Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Patients preparing to undergo therapies that pose a risk to their fertility or who are at risk of premature ovarian insufficiency should be provided prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document entitled “Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion,” last published in 2019.

Original language	English (US)
Pages (from-to)	247-259
Number of pages	13
Journal	Fertility and sterility
Volume	125
Issue number	2
DOIs	https://doi.org/10.1016/j.fertnstert.2025.12.001
State	Published - Feb 2026

Keywords

Fertility preservation
infertility
premature ovarian insufficiency
reproductive endocrinology

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2025.12.001

Cite this

@article{63cc49ba97e34de2904b50d5edd137a2,

title = "Fertility preservation in patients with medical indications: a committee opinion",

abstract = "Patients preparing to undergo therapies that pose a risk to their fertility or who are at risk of premature ovarian insufficiency should be provided prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document entitled {\textquotedblleft}Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion,{\textquotedblright} last published in 2019.",

keywords = "Fertility preservation, infertility, premature ovarian insufficiency, reproductive endocrinology",

author = "\{Practice Committee of the American Society for Reproductive Medicine\} and Clarisa Gracia and Paula Amato and Jacob Anderson and Rebecca Flyckt and Karl Hansen and Micah Hill and Jain, \{Tarun M.\} and Sangita Jindal and Suleena Kalra and Bruce Pier and Denny Sakkas and Anne Steiner and Cigdem Tanrikut and Mark Trolice and Suneeta Senapati and Ryan Smith and Plowden, \{Torie C.\} and Belinda Yauger and Robert Brannigan and Elizabeth Ginsburg and Jared Robins and Shannon, \{Chevis N.\} and Jessica Goldstein and Madeline Brooks",

note = "Publisher Copyright: {\textcopyright} 2025 American Society for Reproductive Medicine",

year = "2026",

month = feb,

doi = "10.1016/j.fertnstert.2025.12.001",

language = "English (US)",

volume = "125",

pages = "247--259",

journal = "Fertility and sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Fertility preservation in patients with medical indications

T2 - a committee opinion

AU - Practice Committee of the American Society for Reproductive Medicine

AU - Gracia, Clarisa

AU - Amato, Paula

AU - Anderson, Jacob

AU - Flyckt, Rebecca

AU - Hansen, Karl

AU - Hill, Micah

AU - Jain, Tarun M.

AU - Jindal, Sangita

AU - Kalra, Suleena

AU - Pier, Bruce

AU - Sakkas, Denny

AU - Steiner, Anne

AU - Tanrikut, Cigdem

AU - Trolice, Mark

AU - Senapati, Suneeta

AU - Smith, Ryan

AU - Plowden, Torie C.

AU - Yauger, Belinda

AU - Brannigan, Robert

AU - Ginsburg, Elizabeth

AU - Robins, Jared

AU - Shannon, Chevis N.

AU - Goldstein, Jessica

AU - Brooks, Madeline

PY - 2026/2

Y1 - 2026/2

N2 - Patients preparing to undergo therapies that pose a risk to their fertility or who are at risk of premature ovarian insufficiency should be provided prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document entitled “Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion,” last published in 2019.

AB - Patients preparing to undergo therapies that pose a risk to their fertility or who are at risk of premature ovarian insufficiency should be provided prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document entitled “Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion,” last published in 2019.

KW - Fertility preservation

KW - infertility

KW - premature ovarian insufficiency

KW - reproductive endocrinology

UR - https://www.scopus.com/pages/publications/105029131882

UR - https://www.scopus.com/pages/publications/105029131882#tab=citedBy

U2 - 10.1016/j.fertnstert.2025.12.001

DO - 10.1016/j.fertnstert.2025.12.001

M3 - Article

C2 - 41494900

AN - SCOPUS:105029131882

SN - 0015-0282

VL - 125

SP - 247

EP - 259

JO - Fertility and sterility

JF - Fertility and sterility

IS - 2

ER -

Fertility preservation in patients with medical indications: a committee opinion

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this